It must be mentioned that in breast carcinomas, histological characteristics are not correlated with molecular subtypes that predict response to certain forms of therapy (e.g. response to hormonal or anti-HER2 therapy)60,62. The gene discussed is ERBB2; the disease is breast carcinoma.